Activity Description & Educational Objectives
In this activity, experts in chronic obstructive pulmonary disease (COPD) discuss the diagnosis and management of COPD, with an emphasis on assessing and reducing exacerbations.
Upon completion of this activity, participants should be better able to:
- Describe strategies for determining patients at risk for exacerbations, including appropriate patient assessment and use of spirometry
- Discuss recently updated recommendations from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) as they relate to assessing and controlling exacerbations in patients with chronic obstructive pulmonary disease (COPD)
- Evaluate the efficacy and safety of strategies to reduce exacerbations in COPD
- Explain the benefits of a healthcare provider team approach to the management of patients with COPD, recognizing the importance of the relationship between the pulmonologist and primary care physician
This activity has been designed to meet the educational needs of pulmonologists, primary care physicians, nurse practitioners, physician assistants, pharmacists and other clinicians involved in the management of patients with COPD.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release and Expiration Dates: February 05, 2013 - February 04, 2014
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, National Jewish Health has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director and Interviewee
Barry J. Make, MD
Professor, Department of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Denver School of Medicine
Co-Director, COPD Program
National Jewish Health
Barry J. Make, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Boehringer Ingelheim; Forest Laboratories, Inc.; and GlaxoSmithKline.
Speakers Bureau participant with Boehringer Ingelheim and GlaxoSmithKline.
Advisory Board for AstraZeneca; Boehringer Ingelheim; Forest Laboratories, Inc.; GlaxoSmithKline; Ikaria, Inc., Breathe; Novartis Corporation; and Sunovion Pharmaceuticals Inc.
Other Financial or Material Support from Forest Laboratories, Inc.
Stuart W. Stoloff, MD, FAAAAI, FAFP
Clinical Professor of Family & Community Medicine
University of Nevada School of Medicine
Stuart W. Stoloff, MD, FAAAAI, FAFP, has a financial interest/relationship or affiliation in the form of:
Consultant for Aerocrine and Inspirix.
Speakers Bureau participant with Dey Pharma.
Harold Nelson, MD
Professor of Medicine
Division of Allergy and Immunology
National Jewish Health and University of Colorado School of Medicine
Harold Nelson, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Circassia and Merck & Co. Inc.
Grant/Research Support from Circassia; Lincoln Diagnostics, Inc.; National Institutes of Health (NIH); and Rigel.
Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education
Kathryn B. Charalambous, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
The National Jewish Health ("NJH") and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, "NJH Parties") shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of National Jewish Health and PVI, PeerView Institute for Medical Education. National Jewish Health is accredited by the ACCME to provide continuing medical education for physicians.
National Jewish Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Forest Laboratories, Inc.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.